ARK Genomic Revolution ETF (NY:ARKG)

54.00 +0.83 (+1.56%)

Official Closing Price Updated: 8:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ARK Genomic Revolution ETF

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday ↗

December 20, 2021

Cathie Wood’s Ark Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc (NASDAQ: QSI). Shares of the medical...

Via Benzinga

Biotech Playbook 2021: No Help From Small Caps In Q4 ↗

December 14, 2021

Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but...

Via Talk Markets

Bionano Genomics Proves Not Everything Genetic is Gold ↗

December 01, 2021

Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes.

Via InvestorPlace

Cathie Wood Testing 'ARK On Steroids' As ARK Funds Struggle ↗

November 24, 2021

Wood said ARK is testing a strategy to short stocks in the big benchmark indexes,

Via Investor's Business Daily

Topics Electric Vehicles

Neck Cream Reversal ↗

November 18, 2021

Cathie Wood's ARKG is down about 50% over the past 9 months.

Via Talk Markets

Don't Look Now, But Cathie Wood's Ark Is Taking On Water ↗

November 24, 2021

Among the biggest losers over the last 48 hour tech stock volatility has been...well, everything in Cathie Wood's

Via Talk Markets

Biotech Stocks are Due for a Rally ↗

November 22, 2021

There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums.

Via Talk Markets

Yes, Cathie Wood's $700,000 Bitcoin Price Prediction Is Legit ↗

November 21, 2021

A Bitcoin price prediction of $700,000 - more than 10 times the recent price - would strike most people as delusional. But this eye-popping target doesn't come from a Bitcoin fan. It comes from Wall...

Via Talk Markets

Tesla (TSLA) Not Enough To Lift ARK Innovation (ARKK) ↗

October 27, 2021

An updated look at Cathie Wood’s ARK ETFs relative strength versus the S&P 500 SPY ETF.

Via Talk Markets

Topics Stocks

ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM ↗

October 21, 2021

The search for therapies tackling chronic illnesses like cancer, diabetes, and heart disease has put stocks in the biotechnology and genomics industry sector on center stage.

Via Talk Markets

Ginkgo Bioworks Stock Drops 20% After Short Sellers Call Company A 'Colossal Scam' ↗

October 06, 2021

Shares of synthetic biology company Ginkgo Bioworks Holdings Inc (NYSE:

Via Benzinga

Mike Khouw Sees Unusual Options Activity In ARK Genomic Revolution ETF ↗

September 29, 2021

On CNBC's "Options Action," Mike Khouw said ARK Genomic Revolution ETF (BATS: ARKG) was active on Tuesday as it traded six times its average daily put volume....

Via Benzinga

Biotech Playbook Revisited As Technicals Weaken ↗

September 27, 2021

Recent breakthroughs with mRNA vaccines over the past two years have shown the enormous potential for transformative therapies. DNA sequencing took off five years ago and new applications are still...

Via Talk Markets

Look For The Q4 Biotech Bounce In Mid-Small Caps ↗

September 17, 2021

Large-cap biopharma stocks are off their highs because of prospects that drug prices may be directly negotiated through Medicare but several Democrats are not in agreement as to how this could be best...

Via Talk Markets

Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market ↗

September 09, 2021

Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day.

Via Talk Markets

3 Healthcare Stocks Cathie Wood Loves Right Now ↗

September 03, 2021

Here's why the founder and CEO of ARK Invest set her sights on these three healthcare stocks.

Via The Motley Fool

Healthcare Stocks Hit New Highs but Small Caps Lag ↗

August 23, 2021

Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field.

Via Talk Markets

Cathie Wood's Ark Adds Another $29M To Palantir Stake After Q2 Earnings Beat, Buys DraftKings On Dip ↗

August 15, 2021

Cathie Wood-led Ark Invest on Friday snapped up 1.156 million shares — estimated to be worth about $28.78 million — in...

Via Benzinga

Topics Earnings

Palantir, Alibaba, Square, Twitter, DraftKings — Stocks Cathie Wood's Ark Bought Or Sold On Thursday ↗

August 13, 2021

Cathie Wood-led Ark Invest on Thursday increased the exposure in Palantir Technologies Inc (NYSE...

Via Benzinga

Teladoc's Earnings Had 1 Important Metric for Both Bulls and Bears ↗

August 08, 2021

Which story do you believe?

Via The Motley Fool

As Zymergen Crashes 76%, Cathie Wood Piles Up $2.5M Worth Of Shares ↗

August 05, 2021

A bullish Ark Invest on Wednesday more than doubled its stake in Zymergen Inc (NASDAQ: ZY) after it plummeted due to the company’s “immaterial” revenue...

Via Benzinga

Q2 Growth 'Nothing Short Of Virtuous': Economist ↗

July 29, 2021

The coronavirus pandemic that began in 2020 and is persisting today has led many investors to hold poor market expectations. But maybe they shouldn’t be so pessimistic. What...

Via Benzinga

Cathie Wood Doubles Down On Teladoc, Spotify, Shopify As Stocks See Earnings-Related Dips ↗

July 29, 2021

Cathie Wood-led Ark Investment Management on Wednesday piled up 713,842 shares, estimated to be worth about $108.37 million, in

Via Benzinga

Cathie Wood's Ark ETFs Underperformed The Broader Market In Q2, With Workhorse, Virgin Galactic, Coinbase, Teladoc Taking Big Toll ↗

July 15, 2021

ARK Invest, the New York-based investment management firm led by the popular money manager Cathie Wood, saw its five actively managed exchange-traded funds and two self-indexed...

Via Benzinga

A Comprehensive Guide To Genomic ETFs ↗

July 11, 2021

Given the growing applications of gene-editing, it is a rising market which offers endless opportunities. Growing demand for personalized medicine, solid investments and higher R&D activities will soon...

Via Talk Markets

Where Will ARK Genomic Revolution ETF Be in 5 Years? ↗

July 10, 2021

Cathie Wood's genomics ETF is making big bets on the "Genomic Age."

Via The Motley Fool

Mid-Cap Biotech Picks: Seasonal Rally Underway ↗

July 03, 2021

Many Mid-Cap biotech stocks were hit hard after the February peak. We suggest three new mid-cap biotech picks. All three picks can be volatile but very tradable.

Via Talk Markets

Cathie Wood Piles On Another $59M In Uipath, Sells $2.6M In Roku ↗

June 30, 2021

Cathie Wood-led Ark Investment Management on Tuesday snapped up 858,129 shares, estimated to be worth about $59.12 million, in UiPath Inc (NYSE: PATH) on the dip. Shares of the...

Via Benzinga

These 3 High-Dividend Stocks Have Cathie Wood's Seal of Approval ↗

June 28, 2021

Some might be surprised to see income-paying stocks among the ARK Invest founder's high-growth picks.

Via The Motley Fool

Cathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M ↗

June 27, 2021

Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth about $9.55 million, in UiPath Inc

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.